Cargando…

Acute Myeloid Leukaemia: New Targets and Therapies

Detalles Bibliográficos
Autores principales:	Brown, Geoffrey, Marcinkowska, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751180/ https://www.ncbi.nlm.nih.gov/pubmed/29189736 http://dx.doi.org/10.3390/ijms18122577

Ejemplares similares

Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022)

microRNA expression in acute myeloid leukaemia: New targets for therapy?
por: Fletcher, Daniel, et al.
Publicado: (2022)

Differentiation and Cell Survival of Myeloid Leukemia Cells
por: Studzinski, George P., et al.
Publicado: (2012)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets
por: Marcinkowska, Ewa
Publicado: (2022)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

Targeted Therapy in Leukaemia, Lymphoma and Myeloma
por: Opat, Stephen Samuel
Publicado: (2022)

Acute myeloid leukaemia niche regulates response to L‐asparaginase
por: Kaspers, Gertjan J. L.
Publicado: (2019)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Why are patients with chronic myeloid leukaemia (non-)adherent?
por: Abraham, I, et al.
Publicado: (2012)

MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009)

Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients
por: Greiner, Jochen, et al.
Publicado: (2021)

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
por: Casirati, Gabriele, et al.
Publicado: (2023)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
por: Sandri, Sara, et al.
Publicado: (2017)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic Insights
por: Marcinkowska, Ewa, et al.
Publicado: (2022)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia
por: Skelding, Kathryn A., et al.
Publicado: (2022)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma
por: Waselewski, Alexander, et al.
Publicado: (2018)

Bipartite network models to design combination therapies in acute myeloid leukaemia
por: Jafari, Mohieddin, et al.
Publicado: (2022)

Prognostic Parameters of Acute Myeloid Leukaemia at Presentation
por: Jahic, Azra, et al.
Publicado: (2017)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Rarity of microsatellite alterations in acute myeloid leukaemia.
por: Sill, H., et al.
Publicado: (1996)

Acute Myeloid Leukaemia Presenting as Gaze Palsy
por: Sykakis, Evripidis, et al.
Publicado: (2011)

'Lot's Wife' Syndrome in Acute Myeloid Leukaemia
por: Barnett, M. M.
Publicado: (1984)

ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
por: Hellmich, Charlotte, et al.
Publicado: (2020)

Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives
por: Wagstaff, Megan, et al.
Publicado: (2022)

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
por: Chin, Lynn, et al.
Publicado: (2023)

Antagonizing Retinoic Acid Receptors Increases Myeloid Cell Production by Cultured Human Hematopoietic Stem Cells
por: Brown, Geoffrey, et al.
Publicado: (2016)

Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)

Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes
por: Miari, Katerina E., et al.
Publicado: (2021)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia
por: Huet, Sarah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g8ic93pafkbc79s6as93t8t6da